Egypt Cancer Network USA

Egyptian Islamic Scholar and Former Grand Mufti of Egypt

Egypt Cancer Network 57357 and AFNCI (ECN), a U.S. based 501c3 non-profit (Tax ID: 26-2192003) helping to further cancer education, research, and care as well as medical infrastructure in Egypt.

Facebook
In 57357, with every new day, a child will overcome cancer and will resume his normal life. With your support... https://t.co/2d14ySNhNv
— Egypt Cancer Network (@EgyptCancer) May 17, 2017

Follow on Twitter
Message

Recent study by CCHE57357’s proteomics and Metabolomics team reveals: Two protein complexes were found to hinder a certain type of chemotherapy used in treating thyroid cancer

A recently published research by CCHE 57357’S Genomics team showcases a non-invasive diagnostic biomarker for Acute Myeloid leukemia patients

Dr. Sheikh Ali Gomaa

Recent study by CCHE57357’s proteomics and Metabolomics team reveals: Two protein complexes were found to hinder a certain type of chemotherapy used in treating thyroid cancer

A recently published research by CCHE 57357’S Genomics team showcases a non-invasive diagnostic biomarker for Acute Myeloid leukemia patients

CCHE57357’s researchers conduct a systematic study to evaluate leukemia relapse treatment drugs in terms of effectiveness and cost

Important Links

Facebook

In 57357, with every new day, a child will overcome cancer and will resume his normal life. With your support... https://t.co/2d14ySNhNv
— Egypt Cancer Network (@EgyptCancer) May 17, 2017

Recent study by CCHE57357’s proteomics and Metabolomics team reveals: Two protein complexes were found to hinder a certain type of chemotherapy used in treating thyroid cancer

A recently published research by CCHE 57357’S Genomics team showcases a non-invasive diagnostic biomarker for Acute Myeloid leukemia patients

Dr. Sheikh Ali Gomaa

Recent study by CCHE57357’s proteomics and Metabolomics team reveals: Two protein complexes were found to hinder a certain type of chemotherapy used in treating thyroid cancer

A recently published research by CCHE 57357’S Genomics team showcases a non-invasive diagnostic biomarker for Acute Myeloid leukemia patients

CCHE57357’s researchers conduct a systematic study to evaluate leukemia relapse treatment drugs in terms of effectiveness and cost

Important Links

Newsletter

Facebook

In 57357, with every new day, a child will overcome cancer and will resume his normal life. With your support... https://t.co/2d14ySNhNv— Egypt Cancer Network (@EgyptCancer) May 17, 2017

In 57357, with every new day, a child will overcome cancer and will resume his normal life. With your support... https://t.co/2d14ySNhNv
— Egypt Cancer Network (@EgyptCancer) May 17, 2017